Tradestie Institutional Equity Comparison Engine

CRBG vs FGSN โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-17 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

CRBG Overall Edge

CRBG Captures Institutional Edge (4โ€“0 Pillars ยท 9โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Corebridge Financial, Inc. (CRBG) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, CRBG trades at 6.3x Forward P/E with 20.8% operating margin (+18.6% YoY revenue) versus FGSN at N/M Forward P/E and N/A operating margin (N/A YoY). In options structure, CRBG sits in UNCLASSIFIED (5th %ile IV; Dealer Gamma Walls on Pro) against FGSN sits in UNCLASSIFIED (N/A IV; Dealer Gamma Walls on Pro).

Valuation Winner CRBG
CRBG 6.3x vs FGSN N/M Fwd P/E
Growth & Margin Winner CRBG
Op Margin 20.8% vs N/A ยท YoY +18.6% vs N/A
Momentum & Technical Winner CRBG
1Y +19.9% vs -26.6% ยท 52W Pos 88% vs 7%
Options & Structure Winner CRBG
UNCLASSIFIED (5th %ile IV) vs UNCLASSIFIED (N/A IV)
CRBG NYSE
Corebridge Financial, Inc.
Life Insurance
$34.90
-2.27% 1D
Market Cap $15.9B
1M Return +1.42%
1Y Return +19.85%
Forward P/E 6.3x
Unified AI Score
52.7 / 100 HOLD
Tech 45.0 Fund 44.0 Flow 50.0 Mom 38.9
FGSN NYSE
F&G Annuities & Life, Inc. 7.300% Junior Subordinated Notes due 2065
Life Insurance
$17.32
+0.76% 1D
Market Cap N/A
1M Return -8.79%
1Y Return -26.58%
Forward P/E N/M
Unified AI Score
28.2 / 100 SELL
Tech 14.0 Fund 41.0 Flow 50.0 Mom 59.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: CRBG +19.85% FGSN -26.58% Spread: +46.43 pp (CRBG Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
CRBG TTM Op. Margin: 20.8% FGSN TTM Op. Margin: N/A
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on CRBG vs FGSN. Trailing 12-month operating profitability (CRBG 20.8% vs FGSN N/A) and valuation multiples (CRBG 6.3x vs FGSN N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: CRBG (9) vs FGSN (1)
Institutional Metric CRBG FGSN Criterion Row Winner
Market Capitalization Scale $15.9B N/A Larger Scale CRBG
Trailing P/E Ratio Valuation 8.2x N/M Lower Multiple CRBG
Forward P/E Ratio Valuation 6.3x N/M Lower Multiple CRBG
Revenue Growth (YoY) Growth +18.6% N/A Higher Growth CRBG
Operating Margin (TTM) Profitability 20.8% N/A Higher Margin CRBG
Net Profit Margin Profitability 10.8% N/A Higher Margin CRBG
Return on Equity (ROE) Capital Efficiency 20.1% N/A Higher ROE CRBG
52-Week Range Position Momentum 88% ($22โ€“$37) 7% ($17โ€“$24) Stronger Trend CRBG
Beta / 30D Volatility Risk Regime 1.15ฮฒ ยท 35% Vol 0.30ฮฒ ยท 22% Vol Lower Realized Risk FGSN
Unified Institutional Score Composite Signal 52.7 / 100 (HOLD) 28.2 / 100 (SELL) Higher Composite CRBG

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full CRBG vs FGSN Buy Guide
CRBG UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 5th %ile
IV Regime Compressed (<25th %ile)
Live CRBG Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
FGSN UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile N/A
IV Regime Unclassified
Live FGSN Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither CRBG nor FGSN registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.